CT-Based Radiomics Can Predict the Efficacy of Anlotinib in Advanced Non-Small-Cell Lung Cancer

Figure 2

LASSO regression process of the NCE-CT cohort (a, b) and the CE-CT cohort (c, d).

(a)

(b)

(c)

(d)